Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease

Peter R Sinnaeve1, Mark P Donahue, Peter Grass

  • 1Duke University Medical Center and Duke Clinical Research Institute, Duke University, Durham, North Carolina, United States of America. peter.sinnaeve@uzleuven.be

Plos One
|September 15, 2009
PubMed

Insights

Whole blood gene expression patterns correlate with coronary artery disease severity. This peripheral blood signature mirrors gene expression changes in atherosclerotic arteries, offering insights into atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Genomics

Background:

  • Inflammation is key in atherosclerotic coronary artery disease pathogenesis.
  • The link between whole blood gene expression and coronary disease severity is not well understood.

Purpose of the Study:

  • To determine if peripheral blood gene expression patterns correlate with coronary artery disease (CAD) severity.
  • To investigate if these patterns reflect atherosclerosis extent in the vascular wall.

Main Methods:

  • Analyzed gene expression in 120 CAD patients (CAD index > or = 23) and 121 controls (CAD index = 0).
  • Utilized a coronary artery disease index (CADi) for angiographical severity assessment.
  • Employed partial least squares multivariate regression with 160 identified genes.

Main Results:

  • 160 genes correlated with CADi (rho > 0.2, P<0.003), particularly those in cell growth, apoptosis, and inflammation pathways.
  • A predictive model using these 160 genes achieved high accuracy (r(2) = 0.776, P<0.0001).
  • Gene expression patterns in aortic tissue mirrored peripheral blood findings, confirming the association with atherosclerosis.

Conclusions:

  • A 160-gene expression signature in whole blood correlates with coronary artery disease severity.
  • Peripheral blood gene expression patterns reflect changes occurring in atherosclerotic arteries.
  • This finding suggests blood gene expression can serve as a biomarker for atherosclerosis.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...